Breast cancer therapy-induced menopause rapidly and persistently disrupts vaginal health and microbial ecology

Breast cancer therapies that induce iatrogenic menopause expose premenopausal women to abrupt estrogen deprivation and frequently result in genitourinary syndrome of menopause (GSM), yet the timing and durability of symptom onset and associated changes in vaginal health and ecology remain poorly understood. In this multicentre prospective longitudinal study, 60 premenopausal women with stage I–IIIC breast cancer were followed from before treatment initiation through iatrogenic menopause across four study visits. At each visit, vulvovaginal health, GSM manifestations, vaginal microbiome composition, menopausal status, and general and sexual wellbeing were assessed using gynecologic examination, 16S rRNA amplicon sequencing, serum estradiol measurements and validated questionnaires. Within three months of menopause onset, participants exhibited significant deterioration in vulvovaginal health and an increased prevalence of sexual dysfunction, particularly among those receiving endocrine therapy. Menopause onset was accompanied by a rapid loss of Lactobacillus dominance and an increase in vaginal microbial diversity, with more pronounced changes in endocrine therapy recipients. These microbial shifts persisted for up to 33 months, including among patients who later regained premenopausal estrogen levels, suggesting limited resilience of the vaginal ecosystem. Our findings provide robust longitudinal evidence that iatrogenic menopause rapidly and durably disrupts vaginal health and microbial ecology, underscoring the need for early intervention and supporting the exploration of microbiome-modulating strategies to support survivorship care.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11570017/v1
Primary Topic
Reproductive tract infections research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Breast cancer therapy-induced menopause rapidly and persistently disrupts vaginal health and microbial ecology

Nynke Willers, Ilke De Boeck, Patrick Neven, Jan Decloedt et al.
3 links
Research Square
Reproductive tract infections research
preprint

Breast cancer therapy-induced menopause rapidly and persistently disrupts vaginal health and microbial ecology

Nynke Willers, Ilke De Boeck, Patrick Neven, Jan Decloedt, Sarah Ahannach, Thies Gehrmann, Sarah Lebeer, María Pinedo-Bardales, Paul Enzlin, Tim Van Rillaer, Margo Hiel, Sileny Han
preprint en

Abstract

Breast cancer therapies that induce iatrogenic menopause expose premenopausal women to abrupt estrogen deprivation and frequently result in genitourinary syndrome of menopause (GSM), yet the timing and durability of symptom onset and associated changes in vaginal health and ecology remain poorly understood. In this multicentre prospective longitudinal study, 60 premenopausal women with stage I–IIIC breast cancer were followed from before treatment initiation through iatrogenic menopause across four study visits. At each visit, vulvovaginal health, GSM manifestations, vaginal microbiome composition, menopausal status, and general and sexual wellbeing were assessed using gynecologic examination, 16S rRNA amplicon sequencing, serum estradiol measurements and validated questionnaires. Within three months of menopause onset, participants exhibited significant deterioration in vulvovaginal health and an increased prevalence of sexual dysfunction, particularly among those receiving endocrine therapy. Menopause onset was accompanied by a rapid loss of Lactobacillus dominance and an increase in vaginal microbial diversity, with more pronounced changes in endocrine therapy recipients. These microbial shifts persisted for up to 33 months, including among patients who later regained premenopausal estrogen levels, suggesting limited resilience of the vaginal ecosystem. Our findings provide robust longitudinal evidence that iatrogenic menopause rapidly and durably disrupts vaginal health and microbial ecology, underscoring the need for early intervention and supporting the exploration of microbiome-modulating strategies to support survivorship care.

Research Square
University of Antwerp (BE), Universitair Ziekenhuis Leuven (BE), AZ Sint-Blasius (BE), KU Leuven (BE)
Fonds Wetenschappelijk Onderzoek, Universiteit Antwerpen, Vlaamse regering
Good health and well-being
Reproductive tract infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon